ProfileGDS4718 / 204087_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 83% 75% 86% 82% 97% 93% 83% 81% 84% 85% 79% 88% 96% 92% 83% 82% 94% 90% 85% 85% 85% 81% 84% 86% 93% 78% 94% 84% 95% 87% 97% 80% 79% 90% 94% 94% 83% 83% 75% 84% 93% 89% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6331886
GSM549102patient 115, normal, homogenized [OPG study]8.0879383
GSM549104patient 119, normal, homogenized [OPG study]7.4211475
GSM549108patient 138, normal, homogenized [OPG study]8.4393586
GSM549119patient 077, normal, homogenized [OPG study]8.0035282
GSM549133patient 032, cancer, homogenized [OPG study]11.049397
GSM549139patient 042, cancer, homogenized [OPG study]9.8007493
GSM549099patient 107, normal, homogenized [OPG study]8.1276483
GSM549109patient 139, normal, homogenized [OPG study]7.892381
GSM549110patient 046, normal, homogenized [OPG study]8.2764384
GSM549114patient 063, normal, homogenized [OPG study]8.5874885
GSM549122patient 082, normal, homogenized [OPG study]7.6858779
GSM549134patient 033, cancer, homogenized [OPG study]8.9677188
GSM549136patient 036, cancer, homogenized [OPG study]10.444496
GSM549140patient 044, cancer, homogenized [OPG study]9.5756892
GSM549111patient 047, normal, homogenized [OPG study]8.346183
GSM549113patient 057, normal, homogenized [OPG study]8.2195682
GSM549132patient 031, cancer, homogenized [OPG study]9.9261994
GSM549137patient 038, cancer, homogenized [OPG study]9.2028790
GSM549142patient 047, cancer, homogenized [OPG study]8.098485
GSM549100patient 110, normal, homogenized [OPG study]8.3778785
GSM549107patient 135, normal, homogenized [OPG study]8.4677485
GSM549115patient 068, normal, homogenized [OPG study]8.0944681
GSM549116patient 072, normal, homogenized [OPG study]8.3961384
GSM549120patient 078, normal, homogenized [OPG study]8.5829486
GSM549131patient 030, cancer, homogenized [OPG study]9.8648693
GSM549118patient 074, normal, homogenized [OPG study]7.6256978
GSM549129patient 027, cancer, homogenized [OPG study]9.7444394
GSM549123patient 088, normal, homogenized [OPG study]8.3092584
GSM549124patient 006, cancer, homogenized [OPG study]9.9560395
GSM549126patient 015, cancer, homogenized [OPG study]8.6390287
GSM549128patient 025, cancer, homogenized [OPG study]10.669497
GSM549103patient 117, normal, homogenized [OPG study]7.7006880
GSM549117patient 073, normal, homogenized [OPG study]7.7804379
GSM549138patient 041, cancer, homogenized [OPG study]9.1683390
GSM549141patient 045, cancer, homogenized [OPG study]10.055994
GSM549130patient 028, cancer, homogenized [OPG study]9.7591594
GSM549101patient 111, normal, homogenized [OPG study]8.1427483
GSM549105patient 128, normal, homogenized [OPG study]8.1754483
GSM549106patient 134, normal, homogenized [OPG study]7.4215875
GSM549112patient 048, normal, homogenized [OPG study]8.3149284
GSM549125patient 011, cancer, homogenized [OPG study]9.6995193
GSM549127patient 024, cancer, homogenized [OPG study]8.9103489
GSM549135patient 035, cancer, homogenized [OPG study]10.762897